Not Tagged
Not Tagged
['leusm']
 discussed obe-cel's fast off-rate cd19 binding domain and the potential advantages it could offer over binding domains used in currently marketed cd19-directed car-t therapies. #asco23 #leusm watch now: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.